Synergistic Healing Peptide Blend
Active Substances:
- TB-500 (5 mg)
- BPC-157 (5 mg)
Brand: Peptide Hubs
Unit: 2 mL Vial (10 mg total/vial)
Form: Lyophilized Powder
Laboratory Tested: View Lab Result
USA Domestic: 2-7 Days Delivery
International: 5-20 Days Delivery
Introducing the undisputed champion of recovery: the Peptide Hubs TB 500/BPC 157 10 mg synergistic blend. This expertly formulated combination brings together two of the most powerful reparative peptides in a single, convenient vial, creating an effect greater than the sum of its parts. Designed for athletes who refuse to let injuries dictate their progress, this blend delivers comprehensive, accelerated healing from the systemic level down to the cellular site of damage. With multiple third-party lab tests confirming precise dosing of both peptides, this legit Peptide Hubs product represents the pinnacle of recovery science. When you buy TB 500/BPC 157 by Peptide Hubs, you're not just treating symptoms—you're actively rebuilding stronger, more resilient tissue to get back to peak performance faster than ever thought possible.
Each 2 mL vial contains a precise 1:1 ratio of two high-purity peptides: 5 mg of TB-500 (Thymosin Beta-4 fragment) and 5 mg of BPC-157 (Body Protecting Compound-157), for a total of 10 mg of active lyophilized powder. This balanced formulation is optimized for synergistic action, providing both systemic regulation and targeted local repair in one reconstituted solution.
This blend is the ultimate tool for the dedicated athlete. It delivers rapid, multifaceted recovery from the most common and debilitating training injuries: chronic tendonitis (elbows, shoulders, knees), ligament sprains, muscle tears, and joint inflammation. The synergy means reduced pain and swelling within days, followed by noticeably improved range of motion and strength at the injury site. Beyond acute repair, it serves as a powerful preventive—regular use during intense training blocks strengthens connective tissues, enhances joint lubrication, and drastically reduces systemic inflammation, allowing for higher training frequency and volume. Users report coming back from injuries that would normally sideline them for months in a matter of weeks, often feeling stronger at the healed site than before the injury.
Clinically, both peptides have demonstrated significant therapeutic potential. BPC-157 has shown remarkable efficacy in accelerating the healing of various wounds, including skin, muscle, and tendon, and is notably gastroprotective, aiding in the recovery of gut mucosa and inflammatory bowel conditions. Research highlights its angiogenic and anti-inflammatory properties. TB-500's systemic promotion of cell migration and anti-inflammatory action supports recovery from myocardial infarction, stroke, and corneal injuries. Together, they embody a comprehensive approach to tissue repair. As discussed in a review on healing peptides, their complementary mechanisms make them ideal candidates for complex regenerative medicine applications.
For men addressing acute injuries, a standard protocol is 250-350 mcg of each peptide per day, meaning a total daily dose of 500-700 mcg from the blended vial. This equates to approximately 0.5-0.7 mL of a standard reconstitution (with 2 mL of bacteriostatic water). Administration is typically via subcutaneous injection, and for targeted benefit, injection near the injury site (e.g., shoulder, elbow) can be effective, though systemic effects are still present. A loading phase of 4-6 weeks is common, followed by a lower maintenance dose if needed.
Female users generally find effective results at slightly lower doses, ranging from 200-300 mcg of each peptide per day (400-600 mcg total daily). As with men, a 4-6 week loading phase is standard for acute issues. Women should start at the lower end of the range to assess individual sensitivity and tolerance before adjusting.
The peptides have different pharmacokinetics but complement each other's duration of action. BPC-157 has a relatively short half-life (a few hours), requiring more frequent dosing for sustained local effect. TB-500's metabolites remain active systemically for days. When used together in a daily protocol, this combination ensures continuous local repair signaling from BPC-157 supported by sustained systemic anti-inflammatory and cell-migration promotion from TB-500.
The blend maintains the excellent safety profiles of both individual peptides. Side effects are rare and typically mild. The most common are localized injection site reactions (redness, itching). Some users report temporary mild nausea or lightheadedness when first starting, which usually subsides quickly. There are no known hormonal, androgenic, or significant systemic side effects. The synergistic action does not appear to increase individual peptide toxicity.
There are no absolute contraindications unique to the blend beyond those of the individual components. It should not be used by individuals with known hypersensitivity to either peptide. Standard precaution: those with active cancer or a history of malignant tumors should consult a physician due to the angiogenic and cell-migration promoting properties. Use during pregnancy or breastfeeding is not recommended due to lack of specific studies.
Risk of serious toxicity from overdose is considered very low based on the safety profiles of both peptides. However, significantly exceeding recommended doses could theoretically lead to an exaggerated physiological response, such as excessive angiogenesis or unwanted local tissue growth. Symptoms would likely be an amplification of mild side effects (nausea, injection site reaction). Discontinuation and supportive care are the recommended actions in case of suspected overdose.
While this blend is comprehensive, it can be further enhanced for specific goals. For athletes in heavy anabolic cycles, adding PEG MGF 5 mg can direct more anabolic signaling to recovering muscles and tendons. To combat the systemic oxidative stress from intense training and improve cellular energy for repair, stack with SS-31 50 mg. For those needing deep, restorative sleep to optimize the healing process, consider adding DSIP 10 mg. To support overall growth hormone output for tissue repair and recovery, combine with CJC-1295 No DAC 5 mg. For a comprehensive wellness and longevity approach alongside healing, Epitalon 25 mg can be a valuable addition.
Your order arrives in secure, discreet packaging. Each purchase contains one sealed 2 mL glass vial filled with 10 mg of the pre-blended, lyophilized TB-500 and BPC-157 peptide powder from Peptide Hubs.
Store the unopened, lyophilized vial in a refrigerator between 2°C and 8°C (36°F - 46°F). Protect from light and moisture. Once reconstituted with bacteriostatic water, the blended solution must be kept refrigerated and is typically stable for 4-6 weeks. Do not freeze the reconstituted solution.
This blend leverages a powerful, complementary pharmacological synergy. BPC-157 is a stable gastric pentadecapeptide that promotes healing primarily through upregulation of growth factors (VEGF, FGF, TGF-β), leading to robust angiogenesis (new blood vessel formation) and granulation tissue formation at the specific injury site. It also modulates the NO-system, reducing inflammation and pain. TB-500 (Thymosin Beta-4 fragment) works systemically by binding to actin, enhancing cell migration to sites of injury, and exerting potent anti-inflammatory effects by downregulating pro-inflammatory cytokines (TNF-α, IL-1β). It also promotes keratinocyte and endothelial cell migration. Together, TB-500 systemically coordinates the healing response and reduces global inflammation, while BPC-157 executes focused, local tissue repair and vascularization. This creates a continuous loop of damage signaling, resource mobilization, and targeted reconstruction.
The pre-blended formulation offers three key advantages:
For the most comprehensive healing, a combination approach is ideal. Because the vial contains both peptides, you can choose based on your injury. For systemic issues or multiple aches (e.g., overall joint inflammation), standard subcutaneous injection in abdominal fat is perfect. For a specific, localized injury (e.g., tennis elbow, rotator cuff), subcutaneous injection near the site (within a few inches) is highly effective. This allows BPC-157 to exert strong local effects while TB-500 still provides systemic support. You do not need to inject directly into the muscle or tendon.
For acute, significant injuries, a cycle of 6-8 weeks is typically recommended to fully support the healing process through the inflammatory, proliferative, and remodeling phases. For chronic issues (long-standing tendonitis) or as a preventive measure during intense training, cycles of 4-6 weeks can be very effective. It's common to take a break of 4-6 weeks between cycles to maintain receptor sensitivity. Some athletes run low-dose maintenance protocols (e.g., 250 mcg total every other day) for longer periods.
Yes, significantly. BPC-157 is originally derived from a stomach-protecting protein and is renowned for its potent gastroprotective effects. It accelerates the healing of gut lining ulcers, reduces intestinal inflammation, and can help repair leaky gut syndrome—a common issue for those on harsh oral compounds or extreme diets. While TB-500's primary role is systemic, the blend taken via standard subcutaneous injection will deliver these gut-healing benefits systemically, making it an excellent choice for athletes experiencing GI distress from NSAIDs, antibiotics, or intense physical and dietary stress.
The three independent lab reports spanning from April 2025 to January 2026 are the strongest possible validation of Peptide Hubs' commitment to quality and consistency. They prove this isn't a one-time batch but a reliably manufactured product. Each report consistently shows both peptides dosed at or above the labeled 5 mg (e.g., 5.40/5.71 mg, 5.34/5.61 mg, 5.85/5.97 mg). This transparency guarantees you are purchasing a legit Peptide Hubs product where the synergy is backed by verified, precise dosing in every vial.
Please log in to write TB 500/BPC 157 10 mg review.